会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • HYDROXAMATE AND HYDRAZIDE DERIVATIVES OF POLYAMINES AND THEIR MEDICAL USE AS CHELATING AGENTS
    • 聚氨酯的氢氧化物和氢化衍生物及其作为螯合剂的医药用途
    • WO1993002045A1
    • 1993-02-04
    • PCT/EP1992001598
    • 1992-07-16
    • COCKBAIN, Julian, Roderick, MichaelsonNYCOMED SALUTAR, INC.HIMMELSBACH, Richard, J.RONGVED, PålKLAVENESS, JoSTRANDE, PerDUGSTAD, Harald
    • COCKBAIN, Julian, Roderick, MichaelsonNYCOMED SALUTAR, INC.
    • C07C243/34
    • C07C243/34C07C259/06C07D257/02
    • The present invention provides a compound of formula (I): A[X(CR R )n]mXA or a chelate complex of salt thereof, for use as therapeutic or diagnostic agent wherein in formula (I), each of the groups R and R may independently represent a hydrogen atom or an alkyl or alkoxy group, optionally carrying one or more substituents selected from hydroxy, alkoxy and aryl groups; each X independently represents an oxygen or sulphur atom or a group NA; each A independently represents a hydrogen atom or an alkyl group optionally substituted by a group Y; each Y represents a hydrogen atom, or a group Z, COZ, SO3R , CSZ, PO2Z or B; or one or more pairs of A groups on different X moieties may together form a group [(CR R )nX ]p (CR R )n or a group A on a mid-chain nitrogen may represent a group [(CR R )nX ]p (CR R )nX A where p represents an integer of 0 to 6, and each X independently represents an oxygen or sulphur atom or a group NA where A is as defined for A but may not form part of a group attached to more than one nitrogen atom; or two adjacent groups R and/or A may together form a homo- or heterocyclic saturated or unsaturated 5-7 membered ring containing 0, 1 or 2 ring heteroatoms selected from oxygen, nitrogen and sulphur; m is an integer of 2 to 8; n is an integer of 2 to 4.
    • 本发明提供式(I)化合物:A [X(CR 1 R 2)n] m X A或其盐的螯合络合物,其用作治疗或诊断剂,其中式(I), R 1和R 2中的每一个可以独立地表示氢原子或烷基或烷氧基,任选携带一个或多个选自羟基,烷氧基和芳基的取代基; 每个X独立地表示氧或硫原子或基团NA; 每个A独立地表示氢原子或任选被基团Y取代的烷基; 每个Y表示氢原子,或基团Z,COZ,SO 3 R 6,CSZ,PO 2 Z或B; 或不同X部分上的一对或多对A基团可以一起形成基团[(CR 1 R 2)n X 1] p(CR 1 R 2)n或基团 中链氮可以表示基团[(CR 1 R 2)n X 1] p(CR 1 R 2)n X 1 A,其中p表示0至6的整数 并且每个X 1独立地表示氧或硫原子或NA <1,其中A 1如对A所定义,但不能形成与多于一个氮原子连接的基团的一部分; 或两个相邻基团R 1和/或A可以一起形成含有0,1或2个选自氧,氮和硫的环杂原子的均聚或杂环饱和或不饱和5-7元环; m为2〜8的整数, n为2〜4的整数。
    • 5. 发明申请
    • POLYAZACYCLOALKANES AS DICHELANTS
    • 聚四环素作为狄更斯
    • WO1995009848A2
    • 1995-04-13
    • PCT/GB1994002115
    • 1994-09-29
    • NYCOMED SALUTAR, INC.COCKBAIN, Julian, Roderick, MichaelsonCARVALHO, JoanFELLMANN, Jere, DouglasWATSON, Alan, DavidKOO, Michael
    • NYCOMED SALUTAR, INC.COCKBAIN, Julian, Roderick, Michaelson
    • C07D257/02
    • C07D295/15A61K49/122C07D257/02C07D273/08C07D403/14C07F9/6524
    • This invention relates to dichelants, in particular compounds having two macrocyclic chelant groups linked by a bridge containing an ester or amide bond, especially compounds of formula (V) (wherein each X which may be the same or different is NZ, O or S, at least two Xs being NZ; each Z is a group R or a group CR 2Y, at least one Z, and preferably 2 or 3 Zs, on each macrocyclic ring being a group CR 2Y; each Y is a group CO2H, PO3H, SO3H, CONR 2, CON(OR )R , CNS or CONR NR 2, preferably COOH; m is 0 or 1 or 2, preferably 1; each n is 2 or 3, preferably 2; q is 1 or 2, preferably 1; each R which may be the same or different is a hydrogen atom or an alkyl group optionally substituted by one or more hydroxy and/or alkoxy groups; and D is a bridging group, other than an unsubstituted carbonylaminoethylaminocarbonyl group, having a molecular weight of less than 1000, preferably less than 500, joining two macrocyclic rings via at least one amide or ester bond) and salts and metal chelates thereof.
    • 本发明涉及双耳,特别是具有通过含有酯或酰胺键的桥连接的两个大环螯合剂基团的化合物,特别是具有式(Ⅴ)化合物(其中每个X可以相同或不同的是NZ,O或S, 至少两个X为NZ;每个Z为基团R 1或基团CR 1 2Y,至少一个Z,优选2或3个Z,每个大环上为基团CR 2Y; 每个Y是CO 2 H,PO 3 H,SO 3 H,CONR 2,CON(OR 1)R 1,CNS或CONR 1 NR 1,优选COOH; m是0或1或 2,优选1;每个n为2或3,优选2; q为1或2,优选1;每个R 1可以相同或不同,是氢原子或任选被一个或多个 羟基和/或烷氧基; D是分子量小于1000,优选小于500的未取代的羰基氨基乙基氨基羰基以外的桥连基,通过至少一个酰胺键或酯键连接两个大环)和盐 和金属螯合物。
    • 6. 发明申请
    • CHELANTS AS CONTRAST ENHANCING AGENTS
    • 作为对比增强剂的CHELANTS
    • WO1995007270A1
    • 1995-03-16
    • PCT/GB1994001931
    • 1994-09-06
    • NYCOMED SALUTAR, INC.COCKBAIN, JulianGARRITY, MarthaCROFTS, Shaun, PaulCARVALHO, JoanSTRANDE, PerDUGSTAD, Harald
    • NYCOMED SALUTAR, INC.COCKBAIN, Julian
    • C07D257/02
    • A61K49/0002C07D257/02Y10S514/836
    • The present invention provides a polychelant compound of formula (VII), (wherein each X which may be the same or different is NZ, O or S, at least two Xs being NZ; B is (CR Y) or -N(CR 2Y)-; each Z is a group R or a group CR 2Y, at least one Z being a group CR 2Y; each Y is a group CO2H, PO3H, SO3H, CONR 2, CON(OR )R , CNS or CONR NR 2; m is 0 or 1 or 2; each n is 2 or 3; q is 0 or 1 when B is (CR Y) and 2 when B is N(CR 2Y); p is an integer having a value of at least 2; each R which may be the same or different is a hydrogen atom or an alkyl, aryl or aralkyl group optionally substituted by one or more hydroxy or alkoxy groups, or two R groups on ring atoms or in Z groups together represent a linker group L; each L which may be the same or different represents a bond or an organic linker group having a molecular weight of less than 1000 and salts and chelates thereof. These compounds, especially the di- and trichelates with paramagnetic or heavy metal ions are especially useful as diagnostic imaging contrast agents.
    • 本发明提供一种式(Ⅶ)的聚合物化合物,其中每个X可以相同或不同,为NZ,O或S,至少两个X为NZ; B为(CR 1 Y)或-N (CR 1 2Y) - ;每个Z是基团R 1或基团CR 1Y 2,至少一个Z是基团CR 2Y;每个Y是基团CO 2 H,PO 3 H,SO 3 H ,CONR 1,CON(OR 1)R 1,CNS或CONR 1 NR 12,m为0或1或2;每个n为2或3; q为0或 1,当B为(CR 1)Y)时为2,B为N时为2(CR 1 2Y); p为值至少为2的整数;每个R 1可以相同或不同 任选被一个或多个羟基或烷氧基取代的烷基,芳基或芳烷基或环原子上或Z基团中的两个R 1一起表示连接基团L;每个L可以相同 或不同的表示分子量小于1000的键或有机连接基团及其盐和螯合物,这些化合物,特别是具有顺磁或重金属离子的二 - 和三 - s作为诊断成像造影剂是特别有用的。
    • 10. 发明申请
    • CONTRAST AGENTS
    • 对比剂
    • WO1997043293A1
    • 1997-11-20
    • PCT/GB1997001314
    • 1997-05-14
    • NYCOMED SALUTAR, INC.LONG, JeffreyHOLM, RichardSANDERSON, WilliamYU, Shi-BaoZHENG, Zhiping
    • NYCOMED SALUTAR, INC.
    • C07F13/00
    • A61K49/0433A61K49/04A61K49/0414C07F13/005C07F15/008
    • Compounds of the formula (I): [M6Q8BnL6-n] where M is Re or Rh; each Q is a bridging atom selected from O, S, Se and Te; B is a monovalent non-bridging atom or moiety; L is a PR3 group in which R is C1-6 alkyl or aryl, optionally substituted on the alkyl or aryl group by one or more water-solubilising groups such as an amine or hydroxidy group, or the three R groups together form a C6-10 trivalent group which may also contain up to three nitrogen or oxygen atoms; n is an integer from 0 to 6; and x is an integer from -2 to +4, representing the overall charge of the cluster, which when non-zero is accompanied by one or more counter ions of equal and balancing charge, and contrast media, particularly X-ray contrast media, containing them.
    • 式(I)化合物:[M6Q8BnL6-n] x其中M为Re或Rh; 每个Q是选自O,S,Se和Te的桥连原子; B是单价非桥连原子或部分; L是PR 3基团,其中R是C 1-6烷基或芳基,任选地在烷基或芳基上被一个或多个水溶性基团例如胺或羟基基团取代,或三个R基团一起形成C6- 10个三价基团,其也可以含有至多三个氮原子或氧原子; n为0〜6的整数; 并且x是从-2到+4的整数,表示簇的总电荷,当非零伴随着一个或多个相等和平衡电荷的对立离子时,以及对比介质,特别是X射线造影介质, 包含它们